Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP959997.RAFd4UEfaHZ9lL98PfiHRVZpqPYRSE239oQOjCCvp77G8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP959997.RAFd4UEfaHZ9lL98PfiHRVZpqPYRSE239oQOjCCvp77G8130_assertion type Assertion NP959997.RAFd4UEfaHZ9lL98PfiHRVZpqPYRSE239oQOjCCvp77G8130_head.
- NP959997.RAFd4UEfaHZ9lL98PfiHRVZpqPYRSE239oQOjCCvp77G8130_assertion description "[This mutation highlights the interplay between Y641 and A677 residues in the substrate specificity of EZH2 and identifies another lymphoma patient population that harbors an activating mutation of EZH2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP959997.RAFd4UEfaHZ9lL98PfiHRVZpqPYRSE239oQOjCCvp77G8130_provenance.
- NP959997.RAFd4UEfaHZ9lL98PfiHRVZpqPYRSE239oQOjCCvp77G8130_assertion evidence source_evidence_literature NP959997.RAFd4UEfaHZ9lL98PfiHRVZpqPYRSE239oQOjCCvp77G8130_provenance.
- NP959997.RAFd4UEfaHZ9lL98PfiHRVZpqPYRSE239oQOjCCvp77G8130_assertion SIO_000772 22323599 NP959997.RAFd4UEfaHZ9lL98PfiHRVZpqPYRSE239oQOjCCvp77G8130_provenance.
- NP959997.RAFd4UEfaHZ9lL98PfiHRVZpqPYRSE239oQOjCCvp77G8130_assertion wasDerivedFrom befree-2016 NP959997.RAFd4UEfaHZ9lL98PfiHRVZpqPYRSE239oQOjCCvp77G8130_provenance.
- NP959997.RAFd4UEfaHZ9lL98PfiHRVZpqPYRSE239oQOjCCvp77G8130_assertion wasGeneratedBy ECO_0000203 NP959997.RAFd4UEfaHZ9lL98PfiHRVZpqPYRSE239oQOjCCvp77G8130_provenance.